Stay updated on Milademetan Safety in AML/MDS Clinical Trial

Sign up to get notified when there's something new on the Milademetan Safety in AML/MDS Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Milademetan Safety in AML/MDS Clinical Trial page

  1. Check
    8 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.15.0 to version 2.15.2, indicating a revision in the content.
    Difference
    0.5%
    Check dated 2025-04-30T18:56:18.000Z thumbnail image
  2. Check
    15 days ago
    Change Detected
    Difference
    0.6%
    Check dated 2025-04-23T15:56:03.000Z thumbnail image
  3. Check
    22 days ago
    Change Detected
    Summary
    The web page has undergone significant changes, including the removal of detailed descriptions of the study's phases and participant criteria for a clinical trial on Acute Myelogenous Leukemia, while adding a new version revision and a specific identifier for the study drug.
    Difference
    29%
    Check dated 2025-04-16T13:15:41.000Z thumbnail image
  4. Check
    29 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.14.3 to version 2.14.4.
    Difference
    0.4%
    Check dated 2025-04-09T06:49:56.000Z thumbnail image
  5. Check
    37 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.14.2 to version 2.14.3.
    Difference
    0.4%
    Check dated 2025-04-01T23:00:06.000Z thumbnail image
  6. Check
    44 days ago
    Change Detected
    Difference
    0.3%
    Check dated 2025-03-25T13:41:00.000Z thumbnail image

Stay in the know with updates to Milademetan Safety in AML/MDS Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Milademetan Safety in AML/MDS Clinical Trial page.